These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Antihyperglycemic activity of new 1,2,4-oxadiazolidine-3,5-diones. Malamas MS; Sredy J; McCaleb M; Gunawan I; Mihan B; Sullivan D Eur J Med Chem; 2001 Jan; 36(1):31-42. PubMed ID: 11231047 [TBL] [Abstract][Full Text] [Related]
8. Novel thiazolidine-2,4-diones as potent euglycemic agents. Hulin B; Clark DA; Goldstein SW; McDermott RE; Dambek PJ; Kappeler WH; Lamphere CH; Lewis DM; Rizzi JP J Med Chem; 1992 May; 35(10):1853-64. PubMed ID: 1588563 [TBL] [Abstract][Full Text] [Related]
9. 2-O-carboxymethylpyrogallol derivatives as PTP1B inhibitors with antihyperglycemic activity. Bhattarai BR; Shrestha S; Ham SW; Kim KR; Cheon HG; Lee KH; Cho H Bioorg Med Chem Lett; 2007 Oct; 17(19):5357-60. PubMed ID: 17728130 [TBL] [Abstract][Full Text] [Related]
10. Discovery of imidazo[1,2-b]thiazole derivatives as novel SIRT1 activators. Vu CB; Bemis JE; Disch JS; Ng PY; Nunes JJ; Milne JC; Carney DP; Lynch AV; Smith JJ; Lavu S; Lambert PD; Gagne DJ; Jirousek MR; Schenk S; Olefsky JM; Perni RB J Med Chem; 2009 Mar; 52(5):1275-83. PubMed ID: 19199480 [TBL] [Abstract][Full Text] [Related]
11. New potent antihyperglycemic agents in db/db mice: synthesis and structure-activity relationship studies of (4-substituted benzyl) (trifluoromethyl)pyrazoles and -pyrazolones. Kees KL; Fitzgerald JJ; Steiner KE; Mattes JF; Mihan B; Tosi T; Mondoro D; McCaleb ML J Med Chem; 1996 Sep; 39(20):3920-8. PubMed ID: 8831758 [TBL] [Abstract][Full Text] [Related]
12. Improved metabolic status and insulin sensitivity in obese fatty (fa/fa) Zucker rats and Zucker Diabetic Fatty (ZDF) rats treated with the thiazolidinedione, MCC-555. Upton R; Widdowson PS; Ishii S; Tanaka H; Williams G Br J Pharmacol; 1998 Dec; 125(8):1708-14. PubMed ID: 9886762 [TBL] [Abstract][Full Text] [Related]
13. Substituted dihydrobenzopyran and dihydrobenzofuran thiazolidine-2,4-diones as hypoglycemic agents. Clark DA; Goldstein SW; Volkmann RA; Eggler JF; Holland GF; Hulin B; Stevenson RW; Kreutter DK; Gibbs EM; Krupp MN J Med Chem; 1991 Jan; 34(1):319-25. PubMed ID: 1992133 [TBL] [Abstract][Full Text] [Related]
15. Substituted tetrahydropyrrolo[2,1-b]oxazol-5(6H)-ones and tetrahydropyrrolo[2,1-b]thiazol-5(6H)-ones as hypoglycemic agents. Aicher TD; Balkan B; Bell PA; Brand LJ; Cheon SH; Deems RO; Fell JB; Fillers WS; Fraser JD; Gao J; Knorr DC; Kahle GG; Leone CL; Nadelson J; Simpson R; Smith HC J Med Chem; 1998 Nov; 41(23):4556-66. PubMed ID: 9804695 [TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of novel imidazoline derivatives with potent antihyperglycemic activity in a rat model of type 2 diabetes. Crane L; Anastassiadou M; El Hage S; Stigliani JL; Baziard-Mouysset G; Payard M; Leger JM; Bizot-Espiard JG; Ktorza A; Caignard DH; Renard P Bioorg Med Chem; 2006 Nov; 14(22):7419-33. PubMed ID: 16889967 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and blood glucose lowering effect of novel pyridazinone substituted benzenesulfonylurea derivatives. Rathish IG; Javed K; Bano S; Ahmad S; Alam MS; Pillai KK Eur J Med Chem; 2009 Jun; 44(6):2673-8. PubMed ID: 19171410 [TBL] [Abstract][Full Text] [Related]